{"id":541059,"date":"2021-09-22T09:04:29","date_gmt":"2021-09-22T13:04:29","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/lantern-pharma-ceo-to-present-at-the-benzinga-healthcare-small-cap-conference-on-september-29th\/"},"modified":"2021-09-22T09:04:29","modified_gmt":"2021-09-22T13:04:29","slug":"lantern-pharma-ceo-to-present-at-the-benzinga-healthcare-small-cap-conference-on-september-29th","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/lantern-pharma-ceo-to-present-at-the-benzinga-healthcare-small-cap-conference-on-september-29th\/","title":{"rendered":"Lantern Pharma CEO to Present at the Benzinga Healthcare Small Cap Conference on September 29th"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n DALLAS<\/span>, Sept. 22, 2021<\/span> \/PRNewswire\/ — Lantern Pharma (NASDAQ: LTRN)<\/b>, a clinical stage biopharmaceutical company using its proprietary RADR\u00ae<\/sup> artificial intelligence (“A.I.”) platform to transform the cost, pace, and timeline of oncology drug discovery and development, today announced that Panna Sharma<\/span>, President & CEO of Lantern Pharma will present at the Benzinga Healthcare Small Cap Conference, which is being held virtually from September 29<\/span> \u2013 30, 2021.<\/p>\n

\n

\n
\n \"Lantern
\n <\/a>\n <\/p>\n<\/p><\/div>\n

Mr. Sharma will deliver his corporate presentation on Wednesday, September 29<\/span>th<\/sup> at 11:55 AM ET<\/span> and will also be available for one-on-one meetings throughout the conference.<\/p>\n

Investors can register for the conference here: https:\/\/www.benzinga.com\/events\/small-cap\/healthcare\/<\/a>. <\/p>\n

\n About Lantern Pharma <\/b>\n <\/p>\n

Lantern Pharma (LTRN) is a clinical-stage oncology-focused biopharmaceutical company leveraging its proprietary RADR\u00ae<\/sup> A.I. platform and machine learning to discover biomarker signatures that identify patients most likely to respond to its pipeline of genomically targeted therapeutics. Lantern is currently developing four drug candidates and an ADC program across eight disclosed tumor targets, including two phase 2 programs. By targeting drugs to patients whose genomic profile identifies them as having the highest probability of benefiting from the drug, Lantern’s approach represents the potential to deliver best-in-class outcomes. More information is available at: www.lanternpharma.com<\/a><\/u> and Twitter @lanternpharma.<\/p>\n

\n CONTACTS:
<\/b>
\n Investor Relations
<\/b>
\n David Waldman<\/span>, Crescendo Communications, LLC
IR@lanternpharma.com<\/a>
<\/u>212-671-1021<\/p>\n

\n Public Relations
<\/b>
\n Nicholas Koulermos<\/span>, Vice President \u2013 5W Public Relations
lantern@5wpr.com<\/a>
<\/u>646-843-1812<\/p>\n

\u00a0<\/p>\n

<\/div>\n

\n \"Cision\" View original content to download multimedia:https:\/\/www.prnewswire.com\/news-releases\/lantern-pharma-ceo-to-present-at-the-benzinga-healthcare-small-cap-conference-on-september-29th-301382827.html<\/a><\/p>\n

SOURCE Lantern Pharma<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire DALLAS, Sept. 22, 2021 \/PRNewswire\/ — Lantern Pharma (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR\u00ae artificial intelligence (“A.I.”) platform to transform the cost, pace, and timeline of oncology drug discovery and development, today announced that Panna Sharma, President & CEO of Lantern Pharma will present at the Benzinga Healthcare Small Cap Conference, which is being held virtually from September 29 \u2013 30, 2021. Mr. Sharma will deliver his corporate presentation on Wednesday, September 29th at 11:55 AM ET and will also be available for one-on-one meetings throughout the conference. Investors can register for the conference here: https:\/\/www.benzinga.com\/events\/small-cap\/healthcare\/. About Lantern Pharma Lantern Pharma (LTRN) is a clinical-stage oncology-focused biopharmaceutical company leveraging its proprietary RADR\u00ae A.I. … <\/p>\n

Continue reading “Lantern Pharma CEO to Present at the Benzinga Healthcare Small Cap Conference on September 29th”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-541059","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nLantern Pharma CEO to Present at the Benzinga Healthcare Small Cap Conference on September 29th - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lantern-pharma-ceo-to-present-at-the-benzinga-healthcare-small-cap-conference-on-september-29th\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lantern Pharma CEO to Present at the Benzinga Healthcare Small Cap Conference on September 29th - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire DALLAS, Sept. 22, 2021 \/PRNewswire\/ — Lantern Pharma (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR\u00ae artificial intelligence (“A.I.”) platform to transform the cost, pace, and timeline of oncology drug discovery and development, today announced that Panna Sharma, President & CEO of Lantern Pharma will present at the Benzinga Healthcare Small Cap Conference, which is being held virtually from September 29 \u2013 30, 2021. Mr. Sharma will deliver his corporate presentation on Wednesday, September 29th at 11:55 AM ET and will also be available for one-on-one meetings throughout the conference. Investors can register for the conference here: https:\/\/www.benzinga.com\/events\/small-cap\/healthcare\/. About Lantern Pharma Lantern Pharma (LTRN) is a clinical-stage oncology-focused biopharmaceutical company leveraging its proprietary RADR\u00ae A.I. … Continue reading "Lantern Pharma CEO to Present at the Benzinga Healthcare Small Cap Conference on September 29th"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/lantern-pharma-ceo-to-present-at-the-benzinga-healthcare-small-cap-conference-on-september-29th\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-22T13:04:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/1216507\/Lantern_Pharma_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lantern-pharma-ceo-to-present-at-the-benzinga-healthcare-small-cap-conference-on-september-29th\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lantern-pharma-ceo-to-present-at-the-benzinga-healthcare-small-cap-conference-on-september-29th\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Lantern Pharma CEO to Present at the Benzinga Healthcare Small Cap Conference on September 29th\",\"datePublished\":\"2021-09-22T13:04:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lantern-pharma-ceo-to-present-at-the-benzinga-healthcare-small-cap-conference-on-september-29th\\\/\"},\"wordCount\":262,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lantern-pharma-ceo-to-present-at-the-benzinga-healthcare-small-cap-conference-on-september-29th\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1216507\\\/Lantern_Pharma_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lantern-pharma-ceo-to-present-at-the-benzinga-healthcare-small-cap-conference-on-september-29th\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lantern-pharma-ceo-to-present-at-the-benzinga-healthcare-small-cap-conference-on-september-29th\\\/\",\"name\":\"Lantern Pharma CEO to Present at the Benzinga Healthcare Small Cap Conference on September 29th - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lantern-pharma-ceo-to-present-at-the-benzinga-healthcare-small-cap-conference-on-september-29th\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lantern-pharma-ceo-to-present-at-the-benzinga-healthcare-small-cap-conference-on-september-29th\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1216507\\\/Lantern_Pharma_Logo.jpg\",\"datePublished\":\"2021-09-22T13:04:29+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lantern-pharma-ceo-to-present-at-the-benzinga-healthcare-small-cap-conference-on-september-29th\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lantern-pharma-ceo-to-present-at-the-benzinga-healthcare-small-cap-conference-on-september-29th\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lantern-pharma-ceo-to-present-at-the-benzinga-healthcare-small-cap-conference-on-september-29th\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1216507\\\/Lantern_Pharma_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1216507\\\/Lantern_Pharma_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lantern-pharma-ceo-to-present-at-the-benzinga-healthcare-small-cap-conference-on-september-29th\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Lantern Pharma CEO to Present at the Benzinga Healthcare Small Cap Conference on September 29th\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lantern Pharma CEO to Present at the Benzinga Healthcare Small Cap Conference on September 29th - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/lantern-pharma-ceo-to-present-at-the-benzinga-healthcare-small-cap-conference-on-september-29th\/","og_locale":"en_US","og_type":"article","og_title":"Lantern Pharma CEO to Present at the Benzinga Healthcare Small Cap Conference on September 29th - Market Newsdesk","og_description":"PR Newswire DALLAS, Sept. 22, 2021 \/PRNewswire\/ — Lantern Pharma (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR\u00ae artificial intelligence (“A.I.”) platform to transform the cost, pace, and timeline of oncology drug discovery and development, today announced that Panna Sharma, President & CEO of Lantern Pharma will present at the Benzinga Healthcare Small Cap Conference, which is being held virtually from September 29 \u2013 30, 2021. Mr. Sharma will deliver his corporate presentation on Wednesday, September 29th at 11:55 AM ET and will also be available for one-on-one meetings throughout the conference. Investors can register for the conference here: https:\/\/www.benzinga.com\/events\/small-cap\/healthcare\/. About Lantern Pharma Lantern Pharma (LTRN) is a clinical-stage oncology-focused biopharmaceutical company leveraging its proprietary RADR\u00ae A.I. … Continue reading \"Lantern Pharma CEO to Present at the Benzinga Healthcare Small Cap Conference on September 29th\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/lantern-pharma-ceo-to-present-at-the-benzinga-healthcare-small-cap-conference-on-september-29th\/","og_site_name":"Market Newsdesk","article_published_time":"2021-09-22T13:04:29+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/1216507\/Lantern_Pharma_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lantern-pharma-ceo-to-present-at-the-benzinga-healthcare-small-cap-conference-on-september-29th\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lantern-pharma-ceo-to-present-at-the-benzinga-healthcare-small-cap-conference-on-september-29th\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Lantern Pharma CEO to Present at the Benzinga Healthcare Small Cap Conference on September 29th","datePublished":"2021-09-22T13:04:29+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lantern-pharma-ceo-to-present-at-the-benzinga-healthcare-small-cap-conference-on-september-29th\/"},"wordCount":262,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lantern-pharma-ceo-to-present-at-the-benzinga-healthcare-small-cap-conference-on-september-29th\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1216507\/Lantern_Pharma_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lantern-pharma-ceo-to-present-at-the-benzinga-healthcare-small-cap-conference-on-september-29th\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/lantern-pharma-ceo-to-present-at-the-benzinga-healthcare-small-cap-conference-on-september-29th\/","name":"Lantern Pharma CEO to Present at the Benzinga Healthcare Small Cap Conference on September 29th - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lantern-pharma-ceo-to-present-at-the-benzinga-healthcare-small-cap-conference-on-september-29th\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lantern-pharma-ceo-to-present-at-the-benzinga-healthcare-small-cap-conference-on-september-29th\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1216507\/Lantern_Pharma_Logo.jpg","datePublished":"2021-09-22T13:04:29+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lantern-pharma-ceo-to-present-at-the-benzinga-healthcare-small-cap-conference-on-september-29th\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/lantern-pharma-ceo-to-present-at-the-benzinga-healthcare-small-cap-conference-on-september-29th\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lantern-pharma-ceo-to-present-at-the-benzinga-healthcare-small-cap-conference-on-september-29th\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/1216507\/Lantern_Pharma_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/1216507\/Lantern_Pharma_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lantern-pharma-ceo-to-present-at-the-benzinga-healthcare-small-cap-conference-on-september-29th\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Lantern Pharma CEO to Present at the Benzinga Healthcare Small Cap Conference on September 29th"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/541059","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=541059"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/541059\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=541059"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=541059"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=541059"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}